Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMP945 |
Synonyms | |
Therapy Description |
AMP945 is a selective inhibitor of focal adhesion kinase (Cancer Res 2022;82(12_Suppl):Abstract nr CT511). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMP945 | AMP 945|AMP-945|Narmafotinib | FAK inhibitor 15 | AMP945 is a selective inhibitor of focal adhesion kinase (Cancer Res 2022;82(12_Suppl):Abstract nr CT511). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05355298 | Phase Ib/II | AMP945 | AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | Recruiting | AUS | 1 |